Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers
until further notice
SourceCancer Epidemiology, Biomarkers & Prevention, 20, 1, (2011), pp. 148-159
Article / Letter to editor
Display more detailsDisplay less details
Cancer Epidemiology, Biomarkers & Prevention
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.